In fact, given the hierarchical ER+/ER- subdivision for breast cancer, it is questionable whether ER- subgroups can be correctly defined based on clusters that were derived by using both ER+ and ER- samples, as was done in other studies (for example [21-23]). The gene discussed is ESR1; the disease is breast cancer.